Objective: The meta-analysis aimed to integrate the evidence of randomized control trials to estimate the efficacy of prophylactic tamsulosin on postoperative urinary retention (POUR). Methods: The PubMed, Embase, Web of Science, and Cochrane Library databases were searched through 1 March 2022 using predetermined keywords. Randomized control trials reporting the preventive efficacy of prophylactic tamsulosin against POUR were identified according to the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guideline. Pooled risk ratios (RRs) were calculated using a random-effects model or a fixed-effects model based on the results of heterogeneity assessment. A meta-regression analysis was performed to explore the potential sources of heterogeneity. Results: There were 14 studies with 1102 patients in the Tamsulosin group and 1119 patients in the Control group. The risk of POUR was significantly lower in the Tamsulosin group (156/1102 [14.2%] vs. 238/1119 [21.3%]; RR=0.65; 95% CI: 0.50–0.86; P=0.002; Heterogeneity: I 2=51%; P=0.01). Tamsulosin administration was associated with a higher risk of adverse events (65/614 [10.6%] vs. 39/626 [6.2%]; RR=1.72; 95% CI: 1.19–2.48; P=0.004; Heterogeneity: I 2=0%; P=0.70). The meta-regression identified the mean age of patients as the only potential source of heterogeneity. Subgroup analysis showed that the younger patients (age <50 years) might benefit more from tamsulosin intake (RR=0.36; 95% CI: 0.19–0.70; P=0.003; Heterogeneity: I 2=49%; P=0.14). Conclusions: The current meta-analysis suggested that prophylactic tamsulosin contributed to the prevention of POUR, and younger patients (<50 years) might benefit more from this preventive regimen. Tamsulosin was also associated with a higher risk of adverse events.
Objective: The aim of the present study is to focus on the most popular winter sports programs, and to investigate the global research status and trends in sports-related injuries. Methods: The Web of Science (WoS) Core Collection database was chosen as original data and used for extracting publications on ice and snow sports injuries on 18 February 2022. Articles published in English between 1995 to 2022 were selected for this study. Results: Finally, for the topic search, a sum of 1605 articles were extracted and used for further analysis. The country and journal ranked first—in terms of total number, total citations and the highest H-index of publications—were the USA and American Journal of Sports Medicine, respectively. The affiliation with the most cited publications was the Norwegian School of Sport Sciences. The most influential first author with the most citations (2537 times), the greatest average citations per article (65.05 times) and the highest H-index (26) was Bahr R. Articles were divided into five main clusters based on keyword analysis: injuries study, head and neck damage study, risk study, therapy study and epidemiology study. Studies related to epidemiology and brain damage in ice and snow sports will continue to be research hot topics. Conclusions: In conclusion, our study indicates that the ice and snow sports injuries research domain is more prevalent in North America and Europe. This study contributes to a comprehensive understanding of ice and snow sports injuries and provides hotspot directions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.